LIB Therapeutics announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lerodalcibep, a treatment aimed at lowering low-density ...

Lerodalcibep could be a key treatment option for patients needing additional LDL-C reduction beyond existing therapies. Credit: Katernya Kon via Shutterstock. LIB Therapeutics announced that the US ...

A catalytic mechanism is the sequence of elementary reactions by which a catalytic reaction proceeds. The electrocatalytic reduction of CO 2 involves electron/proton transfers, with hydrogenation ...

Despite much research, the exact molecular mechanism underlying stator function is yet unclear. In a new study, researchers analyzed the flagellar motor in Vibrio alginolyticus using cryo-electron ...

State Key Laboratory of Heavy Oil Processing, College of Chemistry and Chemical Engineering, China University of Petroleum (East China), Qingdao 266580, China ...